General Information
Revision date
2019-06-10
Product name
Methylphenidate HCl Extended Release Tablets, USP 18 mg, 27 mg, 36 mg and 54 mg
Product Synonyms
Methylphenidate HCl Extended Release Tablets, USP
Chemical name
2-Piperidineacetic acid, α-phenyl-, methyl ester, hydrochloride
CAS No.
298-59-9
1.2.1 Relevant identified uses
and weight C14H19NO2 ⋅ HCl
Icons in SDS
Company Information
company name
Ascent Pharmaceuticals Inc
Section 2
SECTION 2: Hazards identification
OSHA EMERGENCY OVERVIEW Caution Statement Narcotic. Accidental Ingestion of large amounts may be harmful. Read package insert prior to use.
Principle Routes of Exposure
Ingestion Eyes: May cause irritation. Skin Contact: with skin may cause irritation. Allergic reactions are possible, Rash. Inhalation: Narcotic. Can irritate the respiratory passages and cause sneezing, coughing, hypersensitivity. Other symptoms will parallel ingestion. Ingestion: Narcotic. Toxic if swallowed. Ingestion may cause gastrointestinal irritation, nausea, vomiting and diarrhea. Ingestion of this product may result in central nervous system stimulation including muscle twitching, generalized weakness, difficulty breathing and coma. May cause headaches and dizziness, Anxiety, Tachycardia, (excessively rapid heartbeat, including rapid and weak pulse). Hypertension (high blood pressure), Mental impairment, Confusion, agitation and/or excitation, Tremors, convulsions, Fever, Dryness of mouth and throat. Effects of Overexposure: Symptoms of overdose include agitation, confusion, convulsions possibly followed by coma. Chronic exposure: Hypersensitivity, may cause habituation or addiction. Carcinogenicity: - Not listed by IARC, NTP and OSHA.